Alfuzosin Hydrochloride Tablet, Extended Release
Product Images NDC 43353-945

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Alfuzosin Hydrochloride (NDC 43353-945). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 10mg (43353 945)

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Alf4 (Alf4)

FDA Label Image

Dia1 (Dia1)

FDA Label Image

Dia10 (Dia10)

FDA Label Image

Dia11 (Dia11)

This text appears to show a comparison between two treatments, one labeled "k- PLACEBO" with 150 patients and the other labeled "Alfuzosin HCl" with 151 patients. It looks like the duration of treatment was 28 days and there may have been some statistical analysis with a p-value reported. However, the context and purpose of this comparison are not clear from the given text alone.*

FDA Label Image

Dia6 (Dia6)

FDA Label Image

Dia7 (Dia7)

FDA Label Image

Dia8 (Dia8)

FDA Label Image

Dia9 (Dia9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.